Species- and sex-specific variations in binding of ochratoxin A by renal proteins in vitro.
The mycotoxin ochratoxin A (OTA) is a potent renal carcinogen in rodents and induces renal fibrosis in pigs. Furthermore, OTA has been associated with the development of renal tumors and nephropathies in humans. Large species- and sex-differences are observed in sensitivity toward OTA-mediated toxicity and carcinogenicity, yet neither the mechanism(s) resulting in OTA toxicity nor the reasons for the observed species- and sex-specificities are known. This paper investigated variations in OTA handling viz binding to renal proteins which could possibly explain the observed differences in OTA susceptibility in vivo and in vitro. The results obtained via a modification of a standard receptor-binding assay demonstrated the presence of at least one homogeneous binding component in renal cortical homogenates from pig, mouse, rat and humans. This component was shown to bind OTA in a specific and saturable manner. A range of compounds selected for their affinity for steroid receptors and/or for various known organic anion transporters were employed in a competition assay to answer the question whether this homogenous OTA binding component represents a steroid-like receptor component or one of the known organic anion transporters of the kidney. Although many of the compounds were able to compete with OTA for protein-binding, the competition patterns displayed a distinct species specificity and did not correspond to the competition patterns associated with presently known organic anion transporters of the kidney in the mouse, rat or human. The data thus suggests the presence of a new organic anion transporter or more likely, a cytosolic binding component of unknown function with high affinity and capacity for OTA binding in humans, rats, mice and possibly pigs.
Heussner
Alexandra H
AH
Environmental Toxicology, University of Konstanz, Germany.
O'Brien
Evelyn
E
Dietrich
Daniel R
DR
D000818:Animals; D027321:Anion Transport Proteins / Q000494:pharmacology*; D001665:Binding Sites; D001667:Binding, Competitive; D002273:Carcinogens / Q000378:metabolism*; D006801:Humans; D007668:Kidney / Q000737:chemistry* / Q000187:drug effects / Q000473:pathology; D051379:Mice; D009793:Ochratoxins / Q000378:metabolism*; D051381:Rats; D012737:Sex Factors; D013552:Swine
D027321:Anion Transport Proteins; D002273:Carcinogens; D009793:Ochratoxins; C025589:ochratoxin A